EnClear Therapies, Inc. — Form D
EnClear Therapies, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-01. The offering totals $2.0M, of which $718K was reported sold. Industry: Other.
Offering
- Filed: 2024-03-01
- Form: D
- Accession: 0001766406-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $718K
- Remaining: $1.3M
- Investors: 8
- Date of first sale: 2024-02-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-506508
Issuer
- Name: EnClear Therapies, Inc.
- CIK: 0001766406
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 603-343-8504
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jason Camm | Director | WALTHAM, MA |
| Anthony DePasqua | Director | Cambridge, MA |
| Jonathan Fleming | Director | Cambridge, MA |
| Kasper Roet | Director | Cambridge, MA |
| Anthony DePasqua | Executive Officer | Cambridge, MA |
More